← Leaderboards
David B Shackelford
University Of California Los Angeles
$6,228,155
Attributed
$6,493,844
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,493,844 · 3
By mechanism
R01$6,493,844 · 3
Top collaborators
- Aaron Elliott Lisberg1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Sean Curtis Bendall$22,064,188
- Juan Enrique Rozengurt$20,476,723
- Alexander M Van Der Bliek$5,926,699
- David A. Nathanson$10,691,258
- Carla M. Koehler$14,340,942
Research focus
Positron-Emission TomographyTumorNon-Small-Cell Lung CarcinomaMutationMitochondriaStructureMutantIn VivoStk11 GeneCancer PatientPhysiologicalLung NeoplasmsMalignant Neoplasm Of LungAreaNovel TherapeuticsDiagnosisNeoplastic CellDissectionCell LineMembrane PotentialsGenetically Engineered MouseComplexMitochondrial MembraneApoptosis
Grant awards (25)
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors$535,514
R01 · FY2025 · CA · contact PI
Investigating mitochondrial networks as a critical determinant of response to antibody drug conjugates in advanced NSCLC$531,379
R01 · FY2025 · CA
Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$429,306
R01 · FY2025 · CA · contact PI
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors$84,314
R01 · FY2025 · CA · contact PI
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors$508,739
R01 · FY2024 · CA · contact PI
Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$407,842
R01 · FY2024 · CA · contact PI
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors$80,098
R01 · FY2024 · CA · contact PI
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors$70,627
R01 · FY2024 · CA · contact PI
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors$33,990
R01 · FY2024 · CA · contact PI
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors$524,804
R01 · FY2023 · CA · contact PI
Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$429,306
R01 · FY2023 · CA · contact PI
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors$72,857
R01 · FY2023 · CA · contact PI
In Vivo Imaging of Mitochondria Structure and Function in Therapy Resistant Lung Tumors$40,651
R01 · FY2023 · CA · contact PI
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors$535,514
R01 · FY2022 · CA · contact PI
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$352,275
R01 · FY2020 · CA · contact PI
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$78,334
R01 · FY2020 · CA · contact PI
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$341,707
R01 · FY2019 · CA · contact PI
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$69,877
R01 · FY2019 · CA · contact PI
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$352,275
R01 · FY2018 · CA · contact PI
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$83,925
R01 · FY2018 · CA · contact PI
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$71,387
R01 · FY2018 · CA · contact PI
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$352,275
R01 · FY2017 · CA · contact PI
Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$83,477
R01 · FY2017 · CA · contact PI
Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$71,096
R01 · FY2017 · CA · contact PI
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer$352,275
R01 · FY2016 · CA · contact PI